The transcription factors HNF1B and Pax2, co-expressed in the Wolffian duct and ureteric bud epithelia, play essential roles during the early steps of mouse kidney development. In humans, heterozygous mutations in these genes display a number of common kidney phenotypes, including hypoplasia and multicystic hypoplastic kidneys. Moreover, a high prevalence of mutations either in HNF1B or PAX2 has been observed in children with renal hypodysplasia. To gain a better understanding of Hnf1b and Pax2 interactions in vivo, we generated compound heterozygous mice for Hnf1b and Pax2 null alleles. We show here that compound heterozygous mutants display phenotypes similar to severe congenital anomalies of the kidney and the urinary tract (CAKUT), including strong hypoplasia of the kidneys, caudal ectopic aborted ureter buds, duplex kidneys, megaureters and hydronephrosis. At a molecular level, compound mutants show a delay in nephron segment and medullar interstitial differentiation, increased apoptosis and a transient decrease in Lim1 and Wnt4 expression. We also observe a perturbation of smooth muscle differentiation around the ureter associated with a local down-regulation in transcript levels of Bmp4 and Tbx18, two key regulators involved in ureter smooth muscle formation, thus explaining, at least in part, megaureters. These results together uncover a novel role of Hnf1b as a modifier of the Pax2 haplo-insufficient phenotype and show that these two transcription factors operate in common pathways governing both kidney morphogenesis and ureter differentiation. This mouse model should provide new insights into the pathogenic mechanisms of human CAKUT, the most frequent developmental defect identified in newborns.
INTRODUCTION
Congenital anomalies of the kidney and the urinary tract (CAKUT) represent a broad range of anomalies, including renal hypoplasia/dysplasia, multicystic dysplasia, agenesis, hydronephrosis, duplex-collecting system, megaureters, hydroureters and ureteropelvic junction obstructions (1, 2) . These abnormalities, which result from defects in normal renal or ureter development, are the most common cause of renal failure in children being sometimes incompatible with life. Thus, a better understanding of the genetics and cellular bases of CAKUT is of particular clinical interest.
Development of the mammalian kidney and the urinary tract is characterized by sequential reciprocal mesenchymalepithelial interactions and mesenchyme to epithelium transitions (MET). It begins with the formation of the nephric ducts or Wolffian ducts (WD) a pair of epithelial tubes that originate from the posterior intermediate mesoderm and extend caudally to join the cloaca. In mice, the ureteric bud (UB) outgrows at E10.5 and invades the surrounding the metanephric mesenchyme (MM) initiating an arborization programme of dichotomic branching events to form the collecting system. The tips of the UB branches induce the adjacent mesenchymal cells to undergo a MET and further differentiate into the different nephron segments (reviewed in 3, 4) . This process of branching and nephron differentiation is reiterated until nephrogenesis is completed shortly after birth. While the proximal part of the UB differentiates into the collecting system, the distal part that lies outside the MM elongates and differentiates into the non-branched ureter. The ureter further differentiates from the initial stalk of the UB by inducing the formation of the surrounding * To whom correspondence should be addressed at: Biologie du Développement, CNRS-UPMC UMR 7622, 9 quai St. Bernard Bât. C, 75005 Paris, France. Tel: +33 (0)144272151; Fax: +33 (0)144273445; Email: silvia.cereghini@snv.jussieu.fr peristaltic muscle and by remodelling the ureter junction into the bladder (1, 5) .
An alteration of the tightly orchestrated interactions between MM and UB leads to severe renal phenotypes ranging from abnormal collecting duct development, nephron deficit, hypodysplastic kidneys to complete kidney agenesis (6, 7) , whereas an alteration in the maturation process of the ureter leads to either physical obstruction or functional malformations including dilated ureters and pelvis, vesico-ureteral reflux (VUR) and hydroureter (1, 5, 8) .
Several key regulatory genes involved in normal kidney development in humans and mice are also sensitive to gene dosage resulting in haplo-insufficient phenotypes. Two of these genes, PAX2 and vHNF1/HNF1B/TCF2 (hereafter named HNF1B), attracted our attention because they play key roles during early mouse urogenital tract development. In humans heterozygous mutations in these genes exhibit a number of similar urinary tract malformations, including renal aplasia and hypodysplasia, medullary cystic kidney disease and CAKUT (7,9 -12) . In addition, it has been recently reported that mutations either in HNF1B or PAX2 are the most common cause of renal hypodysplasia in children (9, 13) .
PAX2 mutations in humans cause the renal coloboma syndrome (RCS), also known as papillo-renal syndrome, an autosomal-dominant disease characterized by optic nerve coloboma, renal hypodysplasia and progressive renal failure in childhood (14-18) (reviewed in 12, 19 ). In contrast, heterozygous mutations of HNF1B cause a more complex syndrome known as renal cyst and diabetes (RCAD) characterized by severe abnormalities of the kidney and of the genital tracts as well as an early onset of diabetes (maturity onset diabetes of the young subtype 5), pancreas hypoplasia and liver dysfunction (11, (20) (21) (22) (23) . The most consistent clinical features of RCAD are renal malformations, including bilateral cysts, severe multicystic dysplasia, oligomeganonephronia, hypoplastic glomerulocystic kidney disease, or even solitary kidney. In both syndromes, a wide variation in the severity of renal anomalies has been observed between and within families, suggesting that the final phenotype may depend on either genetic or environmental modifying factors.
Mouse genetic studies have shown that homozygous deletion of either Pax2 or Hnf1b leads to severe embryonic phenotypes, while the respective heterozygous null mutants exhibit a moderate kidney hypoplasia (Pax2 +/2 ) (24) or do not have any apparent phenotype (Hnf1b +/2 ) (25). Actually, Pax2 homozygous-mutant mice die perinatally and lack kidneys, ureters, oviducts, vas deferens, and epididymis, and display optic nerves, cochlea and CNS defects (24, reviewed in 26) . In addition, the mouse model Pax2 1Neu+/2 , which carries the most common PAX2 human mutation, exhibits a rather variable renal phenotype including hypoplasia, increased UB apoptosis, decreased branching, as well as a 30% incidence of VUR (27, 28) .
Regarding Hnf1b, its constitutive inactivation leads to early lethality by E6.5 due to defective extraembryonic visceral endoderm formation (25) . Tetraploid embryo complementation analyses have shown that Hnf1b, in addition to be involved in early pancreas and liver morphogenesis (29, 30) , is also required for the correct timing of the UB outgrowth and its subsequent branching, as well as WD epithelial maintenance and the initiation of nephrogenesis (31) . In the context of metanephric kidney development, Hnf1b appears to exert these multiple functions in part through the direct control of Pax2 and Wnt9b expression in the epithelium of UB and WD (31) .
These observations together led us to assess whether Hnf1b and Pax2 operate in vivo in a common genetic pathway during mouse kidney development, by using a non-allelic noncomplementation approach. We show, here, that the compound heterozygous for Pax2 and Hnf1b null alleles display severe renal phenotypes not observed in respective heterozygotes, indicating a strong genetic interaction between the two genes. We further show that the compound heterozygous display a delay in the differentiation of nephron segments as well as a global increase in apoptosis that very likely underlies, at least in part, the observed severe renal hypoplasia and global nephron deficit. Interestingly, and in contrast to other Pax2 haplo-insufficient models (32) , hydronephrosis and megaureters in Hnf1b;Pax2 compound mutants appear to result from a functional defect in the ureter smooth muscle differentiation.
RESULTS

Renal malformations in Hnf1b;Pax2 compound heterozygous
To examine potential genetic interactions between Hnf1b and Pax2 genes during kidney development, heterozygous Pax2 and Hnf1b mice for a null allele were intercrossed. Compound heterozygous in a mixed C57BL/6 × 129/Sv genetic background were born at a Mendelian frequency and were viable and fertile. Since the homozygous deletion of each gene was lethal either perinatally (Pax2 2/2 ) (24) or upon implantation (Hnf1b 2/2 ) (25), in subsequent experiments we crossed compound heterozygous with wild-type (wt) OF1 mice, thus generating outbred descendants. Analysis of the urogenital systems at post-natal day 30 (P30) indicated that kidneys of compound heterozygous were significantly smaller than either the single heterozygotes or the wt (Fig. 1A) . Note that this hypoplasia was significantly more severe than that already exhibited by Pax2 +/2 mutants. Consistent with the reduced kidney size, the number of WT1 positive glomeruli and glomerular progenitors on median transversal kidney sections at P1 was also significantly decreased (Fig. 1B) . Histological analysis indicated that, in addition to the severe hypoplasia, compound heterozygous display at a high frequency (37.7%, 17/45) a wide range of abnormal kidney phenotypes (Table 1 and Fig. 1F-H) . These abnormal phenotypes can be subdivided in duplex kidneys with multi-ureter (24.4%, 11/45) and mega-ureter or hydronephrosis (15.5%, 7/45). Interestingly, similar phenotypes are described in CAKUT. While Hnf1b +/2 did not exhibit any obvious kidney phenotype (Fig. 1D) , Pax2 +/2 display, at significantly lower frequency than compound mutants, hypoplasia, duplex kidney (10.9%, 7/64) and only very rarely hydronephrosis (3.1%, 2/ 64) ( Table 1 , Fig. 1E and data not shown). No unilateral renal agenesis was observed in any genotype although the solitary kidney has been found associated with heterozygous human mutations in either PAX2 or HNF1B (11) and in Pax2 1Neu+/2 mice (28). Similarly, no obvious malformations of the genital tracts were observed in any genotype. Whereas duplex kidneys and bilateral hypoplasia were observed from early E11.5 embryos, hydronephrosis was only detected from E16.5 (Table 1) .
These results together indicate a complex genetic interaction between Pax2 and Hnf1b during kidney morphogenesis and strongly suggest that Hnf1b functions as an enhancer of the Pax2 haplo-insufficiency phenotype. Interestingly, part of the phenotypes observed in compound heterozygous mice were also present in human HNF1B mutant carriers (11) , further suggesting that Hnf1b;Pax2 compound heterozygous represent a novel mouse model of the complex urogenital disease associated with heterozygous mutations in either gene.
Renal structure and nephron differentiation
To identify the emergence stage of these developmental abnormalities and further analyse the phenotype of compound mutants, we performed histological and immunohistochemical analyses at different developmental stages using different nephron segment markers.
When there was no hydronephrosis, the global architecture of compound mutant kidneys appeared roughly normal at either E16.5 or P1, with the expected ratios between the cortical and medullar zones even in severe hypoplastic kidneys (In Fig. 1 compare I, J with K, L and data not shown). We also observed cortical pretubular aggregates and an apparently normal nephrogenic and medullar zone without cysts or glomerular hypertrophy (Fig. 1K and L) . Histological analysis at different stages showed that hydronephrosis appeared around E16.5, when urine begins to be produced ( Fig. 1K ) and was typically associated with a megaureter. Yet a megaureter and duplex kidneys were not necessarily associated with hydronephrosis ( Fig. 1F -H) . Furthermore, in sharp contrast to what is commonly observed in human HNF1B mutations and in rare cases of PAX2 mutations, no cystic structures were observed.
Analysis of nephron patterning and differentiation in E16.5 compound heterozygous kidneys, either hypoplastic or duplicated, showed a strong reduction in the expression of the different nephron markers, including LTA (for proximal tubules), NKCC2 (for a thick ascending Loop of Henle) and NCC (for distal tubules) when compared with the respective heterozygotes (Fig. 2) . The reduced and unequal distribution of these mature nephron segment markers at E16.5 could reflect an absence/reduction of nephron structures and/or a delay in their differentiation. The restoration of nephron marker expression at P1 suggests that in addition to the paucity in nephron structures, there is a delayed differentiation of the different nephron segments. As mentioned above (Fig. 1B) , immunohistochemical analysis of WT1 showed that compound mutants had a decreased number of WT1 positive structures (Fig. 2) .
In contrast, other markers of the collecting duct (DBA, medullar CalbindinD28K, not shown) appeared normally expressed at E16.5 in all genotypes. In the medullar region of compound mutants, interstitial a-smooth muscle actin (SMA) immunostaining was strongly weaker than in the other genotypes. SMA expression was, however, restored by P1, suggesting that similarly to nephron markers, there was a delay in medullar interstitial differentiation. Cortical interstitial development was examined by FoxD1 expression (Fig. 2) . In both compound heterozygous and Pax2 +/2 , the FoxD1 positive domain appeared more expanded than in either wt and Hnf1b +/2 , where its expression domain is narrower and relatively weaker ( Fig. 2 FoxD1, Hnf1b +/2 in insert). Hypoplasia in Pax2 1Neu+/2 has been associated with an increase in apoptosis of ureter bud cells and directly related with the extent of UB branching and nephron number (33) . Interestingly, Pax2 +/2 ;Pax8 +/2 compound heterozygous also exhibit an increase in apoptosis when compared with Pax2 +/2 , particularly in forming nephrons and peripheral mesenchyme (34) .
We, therefore, examined apoptosis at E15.5 by the terminal deoxynucleotidyl transferase, mediated digoxigenin-deoxyuridine nick-end labelling (TUNEL) assay. As shown in Figure 2 , compound heterozygous mutants exhibited a strong increase in cell death when compared with Pax2 +/2 , which exhibited as previously reported (16), a significant increase in apoptosis relative either to wt or Hnf1b heterozygotes. Intriguingly, the highest number of apoptotic cells were located in the cortical mesenchyme close to the capsule in both Pax2 +/2 and compound mutants (47.8% and 52.4% of total apoptosis, respectively) ( Fig. 2) . In contrast, analysis of the percentage of cells positive for the mitotic marker phospho-histone H3 showed comparable numbers of proliferating cells among the different genotypes, in both kidney epithelial tubules and the mesenchymal population (data not shown).
Thus, compound heterozygous kidneys exhibit a delayed differentiation of both nephron segments and medullar interstitium, which is associated with a strong increase in apoptosis that may contribute to the severe hypoplasia and nephron deficit.
Compound heterozygous duplex kidneys form primarily by early division of the UB
To identify the origin of duplex kidneys and analyse the UB branching process in compound mutants, we took advantage of the knock-in lacZ Hnf1b null allele, to stain the epithelium of the urinary tract from E10.5 to E16.5 ( Fig. 3A-D not shown). We also performed in situ hybridization (ISH) at E12.5, using the epithelial Ksp-Cadherin marker (Fig. 3E-G ) to label these structures in all different genotypes and therefore enabling us to count the number of branches and nodes derived from the UB. At this stage, compared with wt (mean: 14.7 branches/metanephros, n ¼ 10), we observed a decrease of 25.18% in the number of branches in compound heterozygous (mean: 10 branches/metanephros, n ¼ 11), while only a decrease of 7.49% in the number of branches in Pax2
(mean: 13.6 branches/metanephros, n ¼ 13). Thus, in compound heterozygous there is a reduction in branching events, which, together with the increased apoptosis, may contribute to the severe hypoplasia (Fig. 3D) . We also observed a reduction in cranial mesonephric tubules in E12.5 compound heterozygous, a phenotype that was also observed in Pax2
embryos (black arrowhead, Fig. 3B , F and G). These analyses also indicate that the duplex kidneys in compound heterozygous appeared to be derived by the duplication of the newly emerging UBs before invading the MM. Thus, duplex kidneys had a common ureter stalk, which was divided at different positions along the ureter (white arrowhead, Fig. 3B , D and G). Moreover, one or two duplication events could occur on the same ureter and bilateral duplex kidneys were observed, but only rarely (Fig. 3B) .
The outgrowth of the UB from the WD at a precise position depends primarily on the Ret-GDNF pathway. Gdnf, expressed in the MM, and its receptor tyrosine kinase Ret, restricted to the WD epithelium, are both required for UB formation and the branching process (35, 36) . Moreover, the position at which the UB emerges is considered a key determinant of the final position at which the ureter will subsequently join the bladder (37) (38) (39) . Recently, a novel pathway involving Gata3-Raldh2-Ret has been shown to be involved in nephric duct insertion (40) . To examine in more detail the consequences of reduced Hnf1b;Pax2 dosage on ureter outgrowth, we first examined the expression of components of the Ret-Gdnf pathway from E10.5 onwards. Interestingly, analysis of the UB marker Ret at E10.5 showed three bubbles or buds in compound heterozygous ( Fig. 3J and K) , instead of a unique bud. Occasionally, we observed blunted and caudal buds relative to the normal UB not connected with the developing metanephros ( Fig. 3G ′ and H). Furthermore, but only very rarely, we observed ectopic blunted buds in the intermediate portion of the WD (not shown), a phenotype that has in general been associated with an expansion of GDNF expression. However, Gdnf whole mount ISH at E9.5 and E10.5 indicated that neither the levels nor the expression domain of Gdnf were significantly altered in Hnf1b;Pax2 compound heterozygous (data not shown).
Epistatic relationships between Pax2 and Hnf1b
We have previously shown that Hnf1b is required for the maintenance of Pax2 expression preferentially in the epithelium of the UB and the WD. These observations together with the results of the HNF1B-ChIP analysis in embryonic kidneys, strongly suggest that Hnf1b directly activates Pax2 in these structures (31) .
To better characterize the genetic interaction between Hnf1b and Pax2, we first examined their reciprocal expressions by performing quantitative RT-PCR (Q-RT -PCR) and ISH on E12.5 metanephric kidneys (Fig. 4A and B) .
When compared with either wt or Hnf1b
+/2 , we observed a 55% decrease in Pax2 transcript levels of compound heterozygous (n ¼ 15), whereas in Pax2 +/2 , the Pax2 transcripts were decreased no .40%. A higher and significant (P ¼ 0.036) decrease compared with Pax2 +/2 was observed when the Pax2 transcript levels of 13 out of the 15 compound mutant kidneys were taken in account. Surprisingly, at this stage there were no significant changes in Hnf1b transcript levels in the four genotypes.
To further examine whether these data result from a specific reduction of Pax2 expression in epithelial UB branches, where Hnf1b and Pax2 are co-expressed, we performed ISH at E12.5 (Fig. 4A) . Unexpectedly, Pax2 expression was similarly decreased both in UB epithelium and in condensed MM in 50% of compound mutants (7 over 13 kidneys), whereas Hnf1b remained globally similar. Note, however, that in the case of Hnf1b-ISH and unlike the Q-RT -PCR data, the in situ probe can detect also low levels of abnormally spliced transcripts produced from the mutant allele (M. Reber & S.C unpublished observations).
Unlike the expression of Pax2 in the UB epithelium, the initial induction of Pax2 in the intermediate mesoderm is not under the control of HNF1B. Indeed, Hnf1b is not expressed in this structure, but in the epithelium of the entire WD as it differentiates from the intermediate mesoderm.
We therefore examined whether Pax2 deficiency could affect the early induction of Hnf1b in the nephric duct, by performing both whole mount ISH and on sagittal sections at E9.5, just before the WD degeneration that occurs in Pax2 2/2 embryos (24). As shown in Figure 4C , Hnf1b was normally expressed in the epithelium of the WD and there was no detectable delay or reduction of Hnf1b transcript levels in Pax2 null embryos compared with Pax2 +/2 . Thus, Hnf1b is expressed in the nephric duct independently of Pax2. To further examine a potential role of Hnf1b dosage during elongation and regionalization of the WD, we also performed double ISH against Ret and Emx2, which label the entire WD. No change was observed in the severity of the phenotype of Hnfb1 +/2 ; Pax2 2/2 embryos when compared with E9.5 Pax2 null mutants, further suggesting that either Hnf1b functions independently of Pax2 in this process or is upstream Pax2 in a linear cascade (data not shown). These results together confirm that Hnf1b is an upstream regulator of Pax2 in the UB epithelium (31) and argue against a potential role for Pax2 in directly regulating Hnf1b expression in the nephric duct.
Subtle deregulations of regulatory pathways in compound heterozygous developing kidneys
In an attempt of placing Hnf1b and Pax2 in the gene regulatory network responsible for UB branching and early nephrogenesis, we examined the expression of different putative target genes that could explain the phenotypes of compound heterozygous embryonic kidneys (Fig. 5A) . As shown in Figure 5 A in compound heterozygous, similar to the observed Pax2 down-regulation (Fig. 4A) , there was a strong decrease in Lim1 expression in pretubular aggregates and their derivatives. This was correlated with a significant reduction in Lim transcript levels by Q-RT -PCR in E12.5 metanephroi (Fig. 5B) .
In contrast, at this stage no significant changes were observed in the mesenchymal expression of other key kidney regulators, including Wnt4, Bmp4, Pax8, GDNF, Six2, Eya1, FoxC1 or FoxC2 (Fig. 5A and data not shown) . Likewise, the epithelial level expression of Ret, Lim1, Wnt11, Wnt9b was equivalent in the different genotypes ( Fig. 5A and B, see also Supplementary Material, Fig. S1A and B for quantification of Lim1 epithelial expression). The global decrease observed in Wnt4 transcripts by Q-RT -PCR (Fig. 5B ), which contrasted with ISH results, was very likely related to the decrease in the number of pretubular aggregates, rather than a decrease in the Wnt4 transcript levels in early nephron precursors. Indeed, quantification of the number of pretubular aggregates on kidney sections indicated a reduction of these structures by 60% in Hnf1b +/2 ;Pax2 +/2 and 39% in Pax2 +/2 when compared with wt. At E14.5, when nephrogenesis has begun, the expression of Wnt4, Lim1, Pod1, FoxC1, Bmp4 and Pax8 in condensed mesenchyme was similar in all the different genotypes ( and data not shown). Likewise, UB tips normally expressed Ret and Wnt11 (Fig. 5A) . However, the low expression of Lim1 at the UB tips was still reduced in compound heterozygous (as shown by a dashed line in Fig. 5A ; data quantified in Supplementary Material, Fig. S1B ), whereas Lim1 expression in early nephron structures was restored at this stage.
Intriguingly, in compound mutants we observed a moderate Wnt4 down-regulation in the medullar collecting ducts, whereas the Wnt4 levels in the surrounding stromal structures were similarly high in all genotypes (Fig. 5A , for quantification see Supplementary Material, Fig. S1B ).
Thus in compound heterozygous Lim expression is transiently down-regulated in pretubular aggregates and at later stages in the UB tips, being the unique transcriptional regulator examined exhibiting a differential expression between WT and compound heterozygous mutants. The subtle decrease in Wnt4 along with the decreased levels of Lim1 may affect the reciprocal interactions between the epithelium and the mesenchyme required for the timing of nephrogenesis and normal medullar differentiation.
Ureter morphogenesis in compound heterozygous
The proper functioning of the ureter depends on the appropriate assembly of muscles coating the urothelium as well as the correct implantation of the most caudal part of the ureter into the bladder. These two processes prevent urine reflux. After budding from the WD at E10.5, the most distal part of the UB, outside of the metanephros, elongates and differentiates into the ureter. Different signalling pathways from the epithelium (Shh), the mesenchyme (Bmp4) and stromal cells (Raldh2) orchestrate a proliferation -differentiation process followed by the reorganization and aggregation of cells around the ureter and their differentiation into smooth muscles (SMs) by E15.5 (8, (41) (42) (43) . The T-box transcription factor Tbx18, expressed in the ureter mesenchyme, is required in synergy with Six1, to maintain the pool of progenitors and Bmp4 expression (44, 45) . Tbx18 also promotes cytodifferentiation of SMs, in association with other factors such as Sox9, DlgH1 and Tshz3 (46 -48). The CAKUT phenotype exhibited by our compound heterozygous could therefore result either from different budding events from the WD, such as the duplication or more caudal budding events reported in other Pax2 heterozygous mutant models (Pax2 +/2 ;Emx2 +/2 and Pax2 1Neu+/2 ), or from defects in ureter maturation and differentiation.
At E16.5, 44% of compound heterozygous exhibited a megaureter associated with an absence of the normal SM ring surrounding the dilated ureter (Fig. 6A) . At this stage, the megaureter was also associated with a flat urothelium where Shh, a secreted molecule that regulates proliferation and differentiation of SM progenitor cells (41), showed either weaker or patchy expression (Fig. 6B) . To further understand this phenotype, we examined SM differentiation before ureter dilation. At E15.5, immunostaining against a-SMA showed that its staining did not form a regular ring and was absent in the ureteropelvic junction region, thus implying a perturbation in SM differentiation (Fig. 6C and D) . The urothelium, in contrast, exhibited an apparently normal morphology and expressed Pan-cytokeratin (CK) (Fig. 6F) .
In compound heterozygous the expression of Tbx18, involved in specifying mesenchymal precursors to become ureteral mesenchyme (44) , was also patchy around the ureter, instead of being homogeneously expressed as in the controls (Fig. 6E) . In duplex ureters, the expression of Tbx18 was mainly restricted to one of the two ureters or sometimes only between them (Fig. 6E) . This local loss of Tbx18 expression was further confirmed on 60 mm sections and was associated with an abnormal muscle differentiation (Fig. 6F) .
Since Tbx18 was reported to be required to maintain Bmp4 expression in the mesenchyme (44), we examined Bmp4 expression at E12.5 and we observed that it was either patchy or strongly decreased around the ureter of compound heterozygous and, in particular, around one of the two ureters in duplex kidneys (Fig. 6G) . This local perturbation of Bmp4 expression in the mesenchyme around the ureter by E12.5 may result during later stages in defective differentiation of SM precursors around the ureter.
Thus, compound heterozygous mutants exhibit a defective maturation of the muscle ring covering the ureter. This is associated with a local loss or decreased expression of Shh, Tbx18 and Bmp4 that very likely leads to the observed delay in muscle differentiation with the megaureter and hydronephrosis as a late consequence.
DISCUSSION
PAX2 and HNF1B are transcription factors implicated in humans in normal tubular morphogenesis and nephron differentiation. We show here that mice compound heterozygous for Hnf1b and Pax2 exhibit a range of complex urogenital phenotypes described in humans as CAKUT (hypo-dysplasia, hydronephros, megaureter and duplex kidneys). We also observe decreased branching, which is associated with an increase in apoptosis, both processes likely contributing to strong hypoplasia of the kidneys. We further show that hydronephrosis and a megaureter is probably the consequence of an early perturbation of Bmp4 and Tbx18 expression around the ureter before muscle differentiation.
Most of the phenotypes displayed by compound heterozygous suggest that Hnf1b functions as a modifier of the Pax2 phenotype. This is consistent with our recent observation that Hnf1b is recruited in vivo to several sites on the Pax2 promoter sequences (31) . These sites are all located within an 8.5 kb region driving Pax2 expression in transgenic mice in the WD and derivatives, but not in the induced MM (49) . These findings provided strong support to the concept that HNF1B is upstream Pax2 in the UB epithelium where both transcription factors co-express and further indicate that different regulatory circuits operate in the epithelium of the WD versus the induced MM. Unexpectedly, however, 50% of compound heterozygous mutants exhibit a global reduction of Pax2 expression in both the UB epithelium and the MM (Fig. 4) , indicating additional non-cell autonomous associated phenotypes. Hnf1b +/2 ;Pax2 +/2 compound mutants exhibit a stronger and higher variable phenotype than the corresponding heterozygous, thus indicating a strong genetic interaction between the two genes. The genetic cooperation observed between Hnf1b and Pax2 is, however, complex. While the heterozygous Hnf1b do not show an apparent phenotype, the heterozygous Pax2 for a null allele analysed in this study exhibit a more modest kidney hypoplasia and duplex kidneys at a much lower frequency than compound mutants. Consistent with the kidney abnormalities exhibited by compound mutants, the expression levels of Pax2 were significantly decreased when compared with Pax2 +/2 . Unexpectedly, we did not detect any significant change in the mRNA levels of Hnf1b among the different genotypes at E12.5. Previous studies either in the embryo (50) or in adult beta cells (51) have shown that despite the detection of relatively high levels of Hnf1b transcripts, the protein was barely detected, indicating a post-transcriptional control of Hnf1b gene expression. Although we have not quantified the HNF1B protein levels, immunostaining analysis did not show a high discrepancy between HNF1B protein and transcript levels (data not shown). We cannot, however, exclude that minor or local variations in HNF1B protein levels below a critical threshold could affect the entire downstream transcriptional circuit. It may also be possible that CAKUT symptoms in compound mutants are the consequence of alterations in the balance levels of HNF1B relative to those of PAX2. Non-allelic noncomplementation observed between two loci, as observed here, has been described when the gene products interact physically or, alternatively, are either in the same or interacting pathways. In co-immunoprecipitation assays, HNF1B and Pax2 did not appear to physically interact (unpublished results) excluding this first possibility. Irrespective of the molecular mechanism, our results show that the phenotype consequences of a reduction in the normal Pax2 gene dosage are significantly exacerbated by a reduction in the Hnf1b gene dosage, suggesting that the two genes cooperate in the regulatory circuits controlling normal morphogenesis of the metanephric kidney and the ureter.
Other observations suggest that part of the phenotypes observed in compound heterozygous may also result from an enhancement of the Hnf1b haploinsufficiency, rather than the Pax2 haploinsufficiency. Indeed, human HNF1B mutant foetuses display a similar deficit in proximal tubules and delayed differentiation (52) as compound mutants. Thus, the dosage effect of these genes results not just from a unique Hnf1b-Pax2 linear cascade. Further studies will be required to address precisely the epistatic relationship between Hnf1b and Pax2 at different stages of kidney development. Our observations are highly reminiscent of the results recently reported in mice compound heterozygous for Pax2 and Emx2 (32). Pax2 +/2 ;Emx2 +/2 mice display duplex systems, bifid ureter and VUR. Although Pax2 appears to act upstream Emx2, molecular analysis suggests that the anomalies observed in Pax2 +/2 ;Emx2 +/2 embryos result, as in our mutants, from anomalies downstream of both transcription factors, as opposed to a simple linear cascade (32) .
The analyses of several mouse models either haploinsufficient or compound heterozygous for Pax2 and for other transcription factors have recently been reported. Compound heterozygous for Pax2 and Pax8, two closely related factors of the Pax gene family, exhibit kidney hypoplasia and increased apoptosis together with reduced levels of Lim1 and Wnt11, suggesting that a reduction in the Pax gene dosage affects the distal nephron differentiation and branching morphogenesis (34) . Although our compound mutants share some phenotypes (increased apoptosis, reduced branching) with Pax2;Pax8 compound heterozygous, other phenotypes are clearly distinct in the two models, indicating that the regulatory circuits affected diverge between them. In our compound mutants, the expression of Lim1 is reduced in nephron progenitors but only transiently, and that of Wnt11 is not affected. We also observed a global delay in nephron segment differentiation, rather than the defective distal nephron differentiation of the Pax2; Pax8 compound heterozygous. Moreover, this delayed differentiation of our mutants is restored at birth. Other phenotypes of our model, such as duplex kidneys, megaureter and hydronephrosis, were not observed in the Pax2;Pax8 compound heterozygous.
The Pax2 +/2 ;Emx2 +/2 compound mice were recently described as presenting duplex kidneys associated with urinary tract obstruction, bifid ureters and a high penetrance (close to 100%) of VUR. VUR has also been described in 30% of Pax2
INeu+/2 (28, 32) . Although these models exhibit apparently similar renal phenotypes to ours, they diverge in the molecular causes of the resulting phenotypes. In these models the primary defect appears to be related to the more caudal insertion of the ureters, which otherwise exhibit a normal SM mesenchymal differentiation. In contrast, the duplex kidneys of the Hnf1b;Pax2 compound heterozygous examined here show a single ureter that appears normally inserted and bifurcates at different positions before contacting the MM. As a consequence duplex kidneys of these mutants are not always associated with hydronephrosis. Instead, a megaureter in our compound mutants is associated with abnormal SM differentiation (see below). Furthermore, neither an increase in the VUR during post-natal life nor a decrease in the embryonic expression of Emx2 was observed in Hnf1b;Pax2 compound mutants (data not shown).
Intriguingly, ISH and Q-RT -PCR analyses of a large panel of putative targets of either HNF1B or PAX2 involved in branching morphogenesis and nephrogenesis show a subtle or transient decrease in the expression of only two regulators, Lim1 and Wnt4. These minor differences, however, do not explain the complex phenotypes observed. We cannot, however, exclude that additional stochastic variations in the expression of Hnf1b and Pax2 and their targets may contribute to the wide spectrum of urinary tract defects.
In contrast to these subtle changes, the local reduction/ absence of SM differentiation around the ureter is very likely the major cause of the megaureter and hydronephrosis in our compound mutants. Indeed, a megaureter in Hnf1b;Pax2 compound mutants appears to result from a functional defect in ureter SM differentiation, correlated with a weak decreased expression of Shh in the ureter epithelium and a local reduction in Bmp4 and Tbx18 expression in the mesenchyme surrounding the ureter. Both Hnf1b and Pax2 (transcripts and protein) are normally expressed along the entire ureter ( Figs 3 and 4 and data not shown), but are absent in the mesenchymal cells surrounding the ureter. It is therefore possible that in compound mutants the decreased levels of the secreted molecule Shh in the ureter epithelium may contribute to reduce in the adjacent ureter SM precursors the levels of both Bmp4 and Tbx18, two key regulators known to control the differentiation of ureter mesenchymal cells into SM and facilitate urothelium maturation (41, 43, 44, 53) .
In conclusion, these results uncover a novel role of Hnf1b as a modifier of the Pax2 haplo-insufficient phenotype and show that these two transcription factors operate in common pathways governing both metanephric kidney morphogenesis and ureter maturation. Our results further suggest that the Hnf1b;Pax2 compound heterozygous represent a novel mouse model of the complex CAKUT symptoms associated with heterozygous mutations in either gene and may provide a mechanistic explanation of a subset of renal syndromes described in the complex diseases RCAD and RCS.
MATERIALS AND METHODS
Embryos and mouse strains
Transgenic mice are heterozygous for the null allele of Pax2 in the C57Bl/6 background [kindly provided by Gruss and Mansouri (24) ] and heterozygous for the null allele of Hnf1b in the 129/sv background, with the LacZ gene replacing the first exon (25) . Timed mating was set up with the day of vaginal plug designated as the 0.5 embryonic day (E0.5). Animals were treated according to protocols approved by the French National Ethical Committee.
Histological analysis, glomerulus counting
Embryo or urogenital systems were dissected in DMEM, fixed in 4% paraformaldehyde, embedded in paraffin and sectioned. Immunostaining against WT1 was performed on P1 median kidney sections and glomeruli were counted. Means were calculated per kidney and genotype. The statistical Student's t-test was performed among genotypes (significance at P , 0.05).
X-Gal staining, immunohistochemistry, TUNEL and in situ hybridization X-Gal staining of heterozygous embryos expressing the LacZ gene into the Hnf1b locus (Hnf1b +/2 and Hnf1b +/2 ;Pax2 +/2 ) was performed as described (25) . Embryos and P1 kidneys were fixed, embedded in paraffin and sectioned. Immunostaining, ISH and whole mount ISH analyses were performed as previously described (30) . Terminal deoxynucleotidyl transferase, mediated digoxigenin-deoxyuridine nick-end labelling (TUNEL) was performed using the Cell Death Detection Kit (Roche) on E15.5 kidney sections. Number of positive cells were divided by the area of kidney section in micrometer square analysed with the Image-J software. The mean and SEM for each genotype are reported in the figures.
E15.5 kidneys and ureters, after whole mount ISH against Tbx18, were embedded in gelatine-sucrose, sectioned by a vibratome and 60 mm sections were used for co-immunostaining against a-SMA and anti-Pan-CK. We used anti-WT1 at 1:100 (Santa Cruz), anti-NKCC2 at 1:100 (provided by M. Knepper), mouse anti-Pan-CK at 1:500 (Sigma), Lectin fluorescein-Lotus tetragonolobus at 1:50 (LTA, Vector) and mouse anti-SMA Cy3 conjugated at 1:500 (Sigma) as primary antibodies. We used biotinylated goat anti-rabbit (Vector) or biotinylated horse anti-mouse (Vector) as the secondary antibody followed by streptavidin-AlexaFluor 488 at 1:500 (Molecular Probes) or the Vectastain ABC kit (Vector laboratories). Nuclei were stained with DAPI (Sigma).
The following RNA probes were used: Hnf1b (29), Lim1 (RR. Behringer), Ret (V. Pachnis), Bmp4 (J. Collignon), Wnt11, Tbx18, FoxD1 (A. Kispert), Pax2, Wnt4 (S. Vainio), Shh (A.P McMahon,), NCC (M. Bouchard). Wnt9b, Emx2, Ksp-Cadherin probes were generated by PCR amplification from E14.5 kidney cDNA. ISH was performed on at least three different embryos for compound heterozygous. The quantification of ISH labelling was done using the Image J software.
RNA extraction and real-time PCR analysis
Both metanephroi of each embryo were dissected at E12.5 in DMEM, washed in PBS and total RNA was extracted using the RNeasy Microkit (Qiagen), and 250 ng were reverse transcribed using the high capacity cDNA reverse transcription kit (Applied Biosystems). Real-time PCR was performed using Fast SYBR Green master mix (Applied Biosystems) and the Step One Plus system (Applied Biosystems). Specific primers were designed for each target gene and, added to the reaction mix with cDNA as according to the manufacturer's protocol. The gene expression level was normalized by cyclophilin A and the relative quantification was calculated by the 2 2DDCT method, at least, in two independent experiments. The mean and SEM were calculated by genotypes and the statistical significance was determined using Student's t-test (significance at P , 0.05).
